LDN MS Treatment
Low Dose Naltrexone: Multiple Sclerosis Treatment Option
The following study was conducted over 6 months on 40 patients with Primary Progressive Multiple Sclerosis (PPMS).
The study concluded that symptoms such as spasticity, pain, fatigue, depression, and quality of life improved in 39 of the 40 patients followed.
Click Here to read more.